COGT
Price
$37.46
Change
-$1.41 (-3.63%)
Updated
Jul 13 closing price
Capitalization
6.4B
28 days until earnings call
Intraday BUY SELL Signals
VNDA
Price
$6.00
Change
-$0.24 (-3.85%)
Updated
Jul 13 closing price
Capitalization
360.21M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs VNDA

COGT vs VNDA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COGT vs. VNDA commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and VNDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (COGT: $37.46 vs. VNDA: $6.00)
Brand notoriety: COGT and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 35% vs. VNDA: 85%
Market capitalization -- COGT: $6.4B vs. VNDA: $360.21M
COGT [@Biotechnology] is valued at $6.4B. VNDA’s [@Biotechnology] market capitalization is $360.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, COGT is a better buy in the long-term than VNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 1 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 5 bearish.
  • VNDA’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, COGT is a better buy in the short-term than VNDA.

Price Growth

COGT (@Biotechnology) experienced а -5.02% price change this week, while VNDA (@Biotechnology) price change was -3.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

COGT is expected to report earnings on Aug 11, 2026.

VNDA is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($6.4B) has a higher market cap than VNDA($360M). COGT YTD gains are higher at: 5.462 vs. VNDA (-31.973). VNDA has higher annual earnings (EBITDA): -147.75M vs. COGT (-345.43M). COGT has more cash in the bank: 866M vs. VNDA (202M). VNDA has less debt than COGT: VNDA (13.1M) vs COGT (239M). VNDA has higher revenues than COGT: VNDA (218M) vs COGT (0).
COGTVNDACOGT / VNDA
Capitalization6.4B360M1,779%
EBITDA-345.43M-147.75M234%
Gain YTD5.462-31.973-17%
P/E RatioN/A126.00-
Revenue0218M-
Total Cash866M202M429%
Total Debt239M13.1M1,824%
FUNDAMENTALS RATINGS
COGT vs VNDA: Fundamental Ratings
COGT
VNDA
OUTLOOK RATING
1..100
4513
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
20100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
3658
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
2190

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COGT's Valuation (73) in the Miscellaneous industry is in the same range as VNDA (91) in the Biotechnology industry. This means that COGT’s stock grew similarly to VNDA’s over the last 12 months.

COGT's Profit vs Risk Rating (20) in the Miscellaneous industry is significantly better than the same rating for VNDA (100) in the Biotechnology industry. This means that COGT’s stock grew significantly faster than VNDA’s over the last 12 months.

COGT's SMR Rating (99) in the Miscellaneous industry is in the same range as VNDA (99) in the Biotechnology industry. This means that COGT’s stock grew similarly to VNDA’s over the last 12 months.

COGT's Price Growth Rating (36) in the Miscellaneous industry is in the same range as VNDA (58) in the Biotechnology industry. This means that COGT’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for COGT (100) in the Miscellaneous industry. This means that VNDA’s stock grew significantly faster than COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTVNDA
RSI
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
72%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
EOS.X0.0740740.002570
+3.59%
EOS cryptocurrency
RPL.X1.7693010.008658
+0.49%
Rocket Pool cryptocurrency
MOB.X0.080365-0.000350
-0.43%
MobileCoin cryptocurrency
SUN.X0.018101-0.000432
-2.33%
Sun [New] cryptocurrency
REN.X0.003189-0.000222
-6.51%
Ren cryptocurrency

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with ENGN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then ENGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
-3.63%
ENGN - COGT
47%
Loosely correlated
-2.11%
DMRA - COGT
46%
Loosely correlated
-1.86%
REPL - COGT
42%
Loosely correlated
-9.60%
QCLS - COGT
39%
Loosely correlated
-4.99%
VERA - COGT
38%
Loosely correlated
-1.19%
More